SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Inns, R.H.
Right arrow Articles by Rice, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inns, R.H.
Right arrow Articles by Rice, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Arsenic
Hazardous Substances DB
*ARSENIC COMPOUNDS
*DIMERCAPROL
*LEWISITE
*SUCCIMER
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Efficacy of Dimercapto Chelatin Agents for the Treatment of Poisoning by Percutaneously Applied Dichloro(2-chlorovinyl)arsine in Rabbits

R.H. Inns

Clinical Toxicology and Pathology Section, Chemical & Biological Defence Establishment, Porton Down, Salisbury, Wiltshire SP4 OJQ, UK

P. Rice

Clinical Toxicology and Pathology Section, Chemical & Biological Defence Establishment, Porton Down, Salisbury, Wiltshire SP4 OJQ, UK

The efficacy of three chelating agents, BAL, DMPS and DMSA has been evaluated in rabbits as treatments for systemic dichloro(2-chlorovinyl)arsine [lewisite] poisoning by the percutaneous route. Chelating agent treatment reduced the incidence and severity of pathological liver changes following lewisite poisoning. There was no marked difference between the three chelating agents for protection against lethality when screened at an equimolar dose of 40 µmol kg-1. The results indicated DMPS and DMSA may prolong survival time compared with BAL.

The low toxicity of DMPS and DMSA compared to BAL enabled doses of 160 µmol kg-1 on a more prolonged dosing schedule to be used for DMPS and DMSA. This schedule showed DMPS and DMSA to give a significant improvement in protection against the lethal effects of percutaneous lewisite compared to that of BAL.

It was concluded that DMPS and DMSA have significant advantages over BAL for use as treatment for systemic lewisite poisoning.

Human & Experimental Toxicology, Vol. 12, No. 3, 241-246 (1993)
DOI: 10.1177/096032719301200307


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement